US Medicare Rx "might hit other benefits"

26 April 2001

A US Senate panel has heard that providing seniors with prescriptiondrug coverage under Medicare could mean them losing the drug benefits which currently provided under their retirement or state plans.

Health consultant Steven Coppock told a hearing of the Senate Finance Committee that one in five companies that provide prescription drug benefits for retirees say they would stop doing so if Medicare were to include such a benefit, reports Reuters. The other companies say they would count on sharing the prescription drug bill for insured seniors with the federal government, he said, adding that he would imagine that some would regard this an an opportunity to exit the business.

Ray Scheppach, executive director of the National Governors Association, told the hearing that the states have shouldered much of these costs for years through Medicaid and state assistance programs. "If a universal benefit is created within the Medicare program, it must truly be a federal benefit," he added.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight